ランチョンセミナー2-8

[LS2-8-1] Radium-223 for Metastatic Castration-resistant Prostate Cancer: The Nuclear Medicine Perspective

^〇Wim J.G. Oyen (Nuclear Medicine and Molecular Imaging The Institute of Cancer Research Consultant in Nuclear Medicine Head of the Dept. of Nuclear Medicine The Royal Marsden NHS Foundation Trust)